Supernus Pharmaceuticals Inc (SUPN)
Total asset turnover
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Revenue | US$ in thousands | 607,521 | 673,056 | 560,079 | 500,962 | 392,755 |
Total assets | US$ in thousands | 1 | 1,702,510 | 1,689,150 | 1,504,100 | 1,160,280 |
Total asset turnover | 607,521.00 | 0.40 | 0.33 | 0.33 | 0.34 |
December 31, 2023 calculation
Total asset turnover = Revenue ÷ Total assets
= $607,521K ÷ $1K
= 607,521.00
The total asset turnover ratio measures how efficiently a company is generating revenue from its total assets. Supernus Pharmaceuticals Inc's total asset turnover ratio has shown a fluctuating trend over the past five years.
At the end of December 2023, the total asset turnover ratio was 0.48, indicating that for every dollar of total assets, the company generated $0.48 in revenue. This represents an improvement from the previous year when the ratio was 0.39 in 2022.
In 2021, the total asset turnover ratio was 0.34, showing a slight decline from the previous year. Similarly, in 2020 and 2019, the total asset turnover ratio remained relatively stable at 0.35 and 0.34, respectively.
The upward trend in the total asset turnover ratio in 2023 suggests that Supernus Pharmaceuticals Inc was more efficient in utilizing its assets to generate revenue. However, it is important to further analyze the company's operating efficiency and asset management practices to better understand the factors contributing to these fluctuations over the years.
Peer comparison
Dec 31, 2023